Primaquine

FDA Approved: * January 23, 1952
Pharm Company: * SANOFI AVENTIS US
Category: Malaria

Primaquine is a medication used to treat and prevent malaria and to treat Pneumocystis pneumonia.[2] Specifically it is used for malaria due to Plasmodium vivax and Plasmodium ovale along with other medications and for prevention if other options cannot be used.[2] It is an alternative treatment for Pneumocystis pneumonia together with clindamycin.[2][3] It is taken by mouth.[2] Common side effects include nausea,... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.
3 Discussions

Dosage List

Primaquine Phosphate 26.3 mg (Primaquine 15 mg) Oral Tablet

NDC: 0024-1596

Labeler:

Sanofi-aventis U.S. LLC

Primaquine Phosphate 26.3 mg (Primaquine 15 mg) Oral Tablet

NDC: 43063-225

Labeler:

Pd-rx Pharmaceuticals, Inc.